Jue Pu
Directeur/Bestuurslid bij LEPU BIOPHARMA CO., LTD.
Vermogen: 63 M $ op 30-04-2024
Actieve functies van Jue Pu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Directeur/Bestuurslid | 22-04-2020 | - |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Directeur/Bestuurslid | 01-10-2018 | - |
Loopbaan van Jue Pu
Eerdere bekende functies van Jue Pu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CG ONCOLOGY, INC. | Directeur/Bestuurslid | 01-03-2019 | 01-10-2023 |
| CG ONCOLOGY, INC. | Directeur/Bestuurslid | 01-01-2010 | 01-01-2018 |
| Oprichter | 01-01-2010 | 01-01-2018 |
Opleiding van Jue Pu
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| Stanford University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| China | 2 |
Operationeel
| Director/Board Member | 4 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Health Technology |
